0 CHECKOUT

PRODUCT FILTERS

REGION

108
34
19
19
17

COUNTRY

13
12
6
5
5

CATEGORIES

  • 73
  • 53
  • 33
  • 25
  • 19
  • 15
  • 10
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

12
34
84
231

PUBLISHED

3
7
47
231

PRODUCT TYPE

222
3
3
1
1
1

Search for: "Analysis of European Biosimilars Market"

The Evolving Landscape in Biosimilars

The outlook for biosimilars has changed dramatically over the last five years, due to product development progress, regulatory guidance, and new company strategies. Biosimilars have now moved well past...

Published:  March 2015
Price:  From

Europe Biosimilars Market & Pipeline Insight

Biosimilars have emerged as one of the most promising segment of the European pharmaceutical industry in recent years. The biosimilars segment has been experiencing a steady growth driven by patent...

Published:  October 2014
Price:  From

Global & USA BioSimilar Market Analysis to 2021

BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating Factor (G-CSF), Anti-Tumor Necrosis Factor (Anti-TNF), Monoclonal Antibodies (MAbs), Insulins, Interferons,...

Published:  August 2015
Price:  From

Global Biosimilars Market, 2015 - 2025

Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously,...

Published:  July 2015
Price:  From

Europe Biosimilars Market Opportunity Outlook 2020

Burgeoning pressure on healthcare system has caused the regulators across the globe to look for suitable therapeutic options. Biologic drugs are commonly used for treatment of various diseases but they...

Published:  November 2015
Price:  From

BIOSIMILARS - Regulatory Framework and Pipeline Analysis

Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative...

Published:  June 2015
Price:  From

Global Biosimilars Industry 2015

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

Published:  February 2015
Price:  From

US Biosimilars Market Opportunity & Clinical Pipeline Analysis

Pharmaceutical companies benefited from the revolution in biotechnology that hit US market in 1980’s. Some of the blockbuster biologics have been introduced in market helping pharmaceutical companies...

Published:  February 2016
Price:  From

Global Cancer Biosimilars Market Opportunity Outlook

Cancer incidences are escalating tremendously across the globe due to which burgeoning pressure has been created on pharmaceutical companies to come forth with viable products. Moreover, presently available...

Published:  June 2015
Price:  From

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production

Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production Summary GBI Research,...

Published:  June 2012
Price:  From

India Biosimilar Market Analysis

As the number of patent expiries of biologic drugs is increasing, Indian companies are developing biosimilar manufacturing capabilities Firms are developing their capabilities by either forming partnerships...

Published:  August 2012
Price:  From

Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth

GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the...

Published:  July 2012
Price:  From

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment Summary GBI Research, the leading business intelligence provider,...

Published:  April 2011
Price:  From

World Biosimilars/Follow-on-Biologics Market - Opportunities and Forecasts, 2014 - 2020

Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference...

Published:  September 2015
Price:  From

Global Biosimilars Market - Products, Applications and Regulations

Off-Patent Biologics to Boost the Growth of Biosimilars Global Market to Reach US$19 4bn by 2018 Several of the leading 25 manufacturers of biosimilars have been entrenched in the market, and have the...

Published:  November 2012
Price:  From

Biosimilars Market by Product (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application - Global Forecast to 2020.

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application...

Published:  July 2015
Price:  From

Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 – a G-CSF & GM-CSF Competitor Analysis

The Competitive Intelligence report Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 – a G-CSF & GM-CSF Competitor Analysis describes product portfolios and R&D pipelines of granulocyte colony...

Published:  July 2015
Price:  From

Analysis of the Global Biosimilars Market

Patent expirations of blockbuster biologics and a promising pipeline of biosimilars present positive opportunities for the global market The research service provides analysis on regional market penetration...

Published:  January 2014
Price:  From

Biosimilars - Global Strategic Business Report

This report analyzes the worldwide markets for Biosimilars in US$ Million The report provides separate comprehensive analytics for US, Europe, and Japan Annual estimates and forecasts are provided for...

Published:  April 2012
Price:  From

The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways

“The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways” provides insights on the biosimilars market revenues and growth until 2015 Further, the distribution...

Published:  December 2009
Price:  From
Loading Indicator

Our Clients

  • Procter & Gamble Co.
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • Bugaboo International B.V.
  • Svenska Cellulosa Aktiebolaget SCA
  • Kimberly-Clark Corporation
  • Medela